DRTS Alpha Tau Medical Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: DRTS

Price (delayed)

$2.49

Market cap

$173.48M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.42

Enterprise value

$174.1M

Highlights
DRTS's EPS is up by 21% YoY but it is down by 20% from the previous quarter
DRTS's net income is down by 16% since the previous quarter but it is up by 14% year-on-year
The debt has surged by 156% year-on-year and by 119% since the previous quarter
The company's quick ratio has shrunk by 53% YoY and by 18% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: NWBO

Key stats

What are the main financial stats of DRTS
Market
Shares outstanding
69.67M
Market cap
$173.48M
Enterprise value
$174.1M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.04
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$22.6M
EBITDA
-$21.53M
Free cash flow
-$24.36M
Per share
EPS
-$0.42
Free cash flow per share
-$0.35
Book value per share
$1.22
Revenue per share
$0
TBVPS
$1.55
Balance sheet
Total assets
$107.39M
Total liabilities
$22.91M
Debt
$13.28M
Equity
$84.48M
Working capital
$78.65M
Liquidity
Debt to equity
0.16
Current ratio
12.07
Quick ratio
11.52
Net debt/EBITDA
-0.03
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-26.4%
Return on equity
-31.9%
Return on invested capital
-20.9%
Return on capital employed
-22.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DRTS stock price

How has the Alpha Tau Medical stock price performed over time
Intraday
5.06%
1 week
3.32%
1 month
-14.14%
1 year
-14.73%
YTD
-17.28%
QTD
-15.59%

Financial performance

How have Alpha Tau Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$35.68M
Net income
-$29.16M
Gross margin
N/A
Net margin
N/A
DRTS's net income is down by 16% since the previous quarter but it is up by 14% year-on-year
The operating income is down by 11% year-on-year and by 6% since the previous quarter

Growth

What is Alpha Tau Medical's growth rate over time

Valuation

What is Alpha Tau Medical stock price valuation
P/E
N/A
P/B
2.04
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
DRTS's EPS is up by 21% YoY but it is down by 20% from the previous quarter
DRTS's P/B is 24% below its last 4 quarters average of 2.7
DRTS's equity is down by 20% YoY and by 6% QoQ

Efficiency

How efficient is Alpha Tau Medical business performance
DRTS's ROE has soared by 67% YoY but it is down by 23% from the previous quarter
Alpha Tau Medical's return on invested capital has surged by 62% YoY but it has decreased by 40% QoQ
The ROA has grown by 37% YoY but it has contracted by 19% from the previous quarter

Dividends

What is DRTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DRTS.

Financial health

How did Alpha Tau Medical financials performed over time
The company's total liabilities has surged by 58% YoY and by 36% QoQ
The company's quick ratio has shrunk by 53% YoY and by 18% QoQ
The debt is 84% smaller than the equity
The debt has surged by 156% year-on-year and by 119% since the previous quarter
DRTS's debt to equity has soared by 129% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.